These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20001666)

  • 1. Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases.
    Ghosh D; Tsokos GC
    Autoimmunity; 2010 Feb; 43(1):48-55. PubMed ID: 20001666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
    Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
    Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
    Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
    J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syk-kinase inhibition prevents mast cell activation in nasal polyps.
    Patou J; Holtappels G; Affleck K; van Cauwenberge P; Bachert C
    Rhinology; 2011 Mar; 49(1):100-6. PubMed ID: 21468383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Involvement of Syk in pathology of systemic autoimmune disease].
    Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Saito K; Akashi K; Tanaka Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):56-61. PubMed ID: 22374444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness.
    Matsubara S; Li G; Takeda K; Loader JE; Pine P; Masuda ES; Miyahara N; Miyahara S; Lucas JJ; Dakhama A; Gelfand EW
    Am J Respir Crit Care Med; 2006 Jan; 173(1):56-63. PubMed ID: 16192454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally.
    Mazuc E; Villoutreix BO; Malbec O; Roumier T; Fleury S; Leonetti JP; Dombrowicz D; Daëron M; Martineau P; Dariavach P
    J Allergy Clin Immunol; 2008 Jul; 122(1):188-94, 194.e1-3. PubMed ID: 18539317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.
    Krishnan S; Juang YT; Chowdhury B; Magilavy A; Fisher CU; Nguyen H; Nambiar MP; Kyttaris V; Weinstein A; Bahjat R; Pine P; Rus V; Tsokos GC
    J Immunol; 2008 Dec; 181(11):8145-52. PubMed ID: 19018007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spleen tyrosine kinase (Syk) regulates systemic lupus erythematosus (SLE) T cell signaling.
    Grammatikos AP; Ghosh D; Devlin A; Kyttaris VC; Tsokos GC
    PLoS One; 2013; 8(8):e74550. PubMed ID: 24013589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the Syk kinase inhibitor R112 by a human mast cell screen.
    Rossi AB; Herlaar E; Braselmann S; Huynh S; Taylor V; Frances R; Issakani SD; Argade A; Singh R; Payan DG; Masuda ES
    J Allergy Clin Immunol; 2006 Sep; 118(3):749-55. PubMed ID: 16950297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus.
    Fleischer SJ; Giesecke C; Mei HE; Lipsky PE; Daridon C; Dörner T
    Arthritis Rheumatol; 2014 Dec; 66(12):3424-35. PubMed ID: 25156507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Camellia japonica suppresses immunoglobulin E-mediated allergic response by the inhibition of Syk kinase activation in mast cells.
    Lee JH; Kim JW; Ko NY; Mun SH; Kim DK; Kim JD; Kim HS; Lee KR; Kim YK; Radinger M; Her E; Choi WS
    Clin Exp Allergy; 2008 May; 38(5):794-804. PubMed ID: 18261158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD45 is essential for Fc epsilon RI signaling by ZAP70, but not Syk, in Syk-negative mast cells.
    Zhang J; Siraganian RP
    J Immunol; 1999 Sep; 163(5):2508-16. PubMed ID: 10452987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun and Ets2 proteins regulate expression of spleen tyrosine kinase in T cells.
    Ghosh D; Tsokos GC; Kyttaris VC
    J Biol Chem; 2012 Apr; 287(15):11833-41. PubMed ID: 22354960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.
    Liao C; Hsu J; Kim Y; Hu DQ; Xu D; Zhang J; Pashine A; Menke J; Whittard T; Romero N; Truitt T; Slade M; Lukacs C; Hermann J; Zhou M; Lucas M; Narula S; DeMartino J; Tan SL
    Arthritis Res Ther; 2013 Oct; 15(5):R146. PubMed ID: 24286216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response.
    Ramis I; Otal R; Carreño C; Domènech A; Eichhorn P; Orellana A; Maldonado M; De Alba J; Prats N; Fernández JC; Vidal B; Miralpeix M
    Pharmacol Res; 2015 Sep; 99():116-24. PubMed ID: 26051661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.
    Moy LY; Jia Y; Caniga M; Lieber G; Gil M; Fernandez X; Sirkowski E; Miller R; Alexander JP; Lee HH; Shin JD; Ellis JM; Chen H; Wilhelm A; Yu H; Vincent S; Chapman RW; Kelly N; Hickey E; Abraham WM; Northrup A; Miller T; Houshyar H; Crackower MA
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1085-92. PubMed ID: 23889698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels.
    Kepley CL
    Int Arch Allergy Immunol; 2005 Sep; 138(1):29-39. PubMed ID: 16088210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
    Braselmann S; Taylor V; Zhao H; Wang S; Sylvain C; Baluom M; Qu K; Herlaar E; Lau A; Young C; Wong BR; Lovell S; Sun T; Park G; Argade A; Jurcevic S; Pine P; Singh R; Grossbard EB; Payan DG; Masuda ES
    J Pharmacol Exp Ther; 2006 Dec; 319(3):998-1008. PubMed ID: 16946104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the activation loop tyrosines of protein tyrosine kinase Syk abrogate intracellular signaling but not kinase activity.
    Zhang J; Kimura T; Siraganian RP
    J Immunol; 1998 Oct; 161(8):4366-74. PubMed ID: 9780214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.